
Sign up to save your podcasts
Or
Coverage of stories discussed this week on ascopost.com:
FDA Approves Daratumumab in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed, Transplant-Ineligible Patients With Multiple Myeloma
4.5
1515 ratings
Coverage of stories discussed this week on ascopost.com:
FDA Approves Daratumumab in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed, Transplant-Ineligible Patients With Multiple Myeloma
116 Listeners
58 Listeners